Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 58,200 shares at $83.85 ($5.0M) on 2023-05-16, disclosed to the SEC on 2023-05-18.
Open-market sale of $5.0M APLS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.17 | 934 | $78K | 1.6% |
| 2 | $83.17 | 934 | $78K | 1.6% |
| 3 | $83.85 | 1,800 | $151K | 3.0% |
| 4 | $85.01 | 14,611 | $1.2M | 24.9% |
| 5 | $85.01 | 14,611 | $1.2M | 24.9% |
| 6 | $85.90 | 3,007 |
| $258K |
| 5.2% |
| 7 | $85.90 | 3,007 | $258K | 5.2% |
| 8 | $87.02 | 7,528 | $655K | 13.1% |
| 9 | $87.02 | 7,528 | $655K | 13.1% |
| 10 | $87.67 | 2,120 | $186K | 3.7% |
| 11 | $87.67 | 2,120 | $186K | 3.7% |
| Total | $85.72 avg | 58,200 | $5.0M | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $226K | — | Filing → |
| APLS | SELL | 2025-08-29 | $12.7M | — | Filing → |
| APLS | SELL | 2025-07-18 | $797K | — | Filing → |